TITLE

Uniform stable-isotope labeling in mammalian cells: formulation of a cost-effective culture medium

AUTHOR(S)
Egorova-Zachernyuk, Tatiana A.; Bosman, Giel J. C. G. M.; DeGrip, Willem J.
PUB. DATE
January 2011
SOURCE
Applied Microbiology & Biotechnology;Jan2011, Vol. 89 Issue 2, p397
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Uniform stable-isotope labeling of mammalian cells is achieved via a novel formulation of a serum-free cell culture medium that is based on stable-isotope-labeled autolysates and lipid extracts of various microbiological origin. Yeast autolysates allow complete replacement of individual amino acids and organic acids in a chemically defined medium (DMEM/F12), enabling a cost-effective formulation of a stable-isotope-labeled culture medium for mammalian cells. In addition, biomass-derived hydrolysates, autolysates, and lipid extracts of various classes of algae were explored as cell culture components, both separately and in combination with yeast autolysates. Optimal autolysate concentrations were established. Such novel medium formulations were tested on mammalian cell lines, often used for recombinant protein production, i.e., Chinese hamster ovary (CHO) and human embryonic kidney (HEK 293). Special attention was paid to the adaptation of these mammalian cell lines to serum-free media. Formulation of the novel proprietary cell culture medium PLIm, based on yeastolates instead of individual amino acids and organic acids, allows a four- to eightfold cost reduction for N and C,N stable-isotope-labeling, respectively, in CHO cells and a three- to sixfold cost reduction in HEK 293 cells. A high level of stable-isotope enrichment of mammalian cells (>90%) was achieved within four passages by complete replacement of carbon and nitrogen sources in the medium with their stable-isotope-labeled analogs. These conditions can be used to more cost-effectively produce labeled recombinant proteins in mammalian cells.
ACCESSION #
56939882

 

Related Articles

  • New Human Embryonic Stem-Cell Lines to Be Made Available to Researchers.  // Ascribe Newswire: Medicine;3/4/2004, p20 

    Howard Hughes Medical Institute researchers at Harvard University announced today that they have derived 17 new human embryonic stem-cell lines. The new cell lines will be made available to researchers, although at this time United States policies prohibit the use of federal funds to investigate...

  • Feeding hungry stem cells. Pedersen, Roger A. // Nature Biotechnology;Sep2002, Vol. 20 Issue 9, p882 

    Reports on research by M. Richards and colleagues demonstrating that two pre-existing human embryonic stem (HES) cell lines retained their undifferentiated state when cultured with human fetal fibroblasts. Theoretical and practical challenges posed by the dependence of HES cells on any feeder...

  • Agouti C57BL/6N embryonic stem cells for mouse genetic resources. Pettitt, Stephen J.; Qi Liang; Rairdan, Xin Y.; Moran, Jennifer L.; Prosser, Haydn M.; Beier, David R.; Lloyd, Kent C.; Bradley, Allan; Skarnes, William C. // Nature Methods;Jul2009, Vol. 6 Issue 7, p493 

    We report the characterization of a highly germline competent C57BL/6N mouse embryonic stem cell line, JM8. To simplify breeding schemes, the dominant agouti coat color gene was restored in JM8 cells by targeted repair of the C57BL/6 nonagouti mutation. These cells provide a robust foundation...

  • Isolation of human iPS cells using EOS lentiviral vectors to select for pluripotency. Hotta, Akitsu; Cheung, Aaron Y. L.; Farra, Natalie; Vijayaragavan, Kausalia; Séguin, Cheryle A.; Draper, Jonathan S.; Pasceri, Peter; Maksakova, Irina A.; Mager, Dixie L.; Rossant, Janet; Bhatia, Mickie; Ellis, James // Nature Methods;May2009, Vol. 6 Issue 5, p370 

    Induced pluripotent stem (iPS) cells may be of use in regenerative medicine. However, the low efficiency of reprogramming is a major impediment to the generation of patient-specific iPS cell lines. Here we report the first selection system for the isolation of human iPS cells. We developed the...

  • Genomic instability of human embryonic stem cell lines using different passaging culture methods. Tosca, Lucie; Feraud, Olivier; Magniez, Aurélie; Bas, Cécile; Griscelli, Frank; Bennaceur-Griscelli, Annelise; Tachdjian, Gérard // Molecular Cytogenetics (17558166);2015, Vol. 8 Issue 1, p1 

    Background: Human embryonic stem cells exhibit genomic instability that can be related to culture duration or to the passaging methods used for cell dissociation. In order to study the impact of cell dissociation techniques on human embryonic stem cells genomic instability, we cultured H1 and H9...

  • Novel lines of Pax6-I- embryonic stem cells exhibit reduced neurogenic capacity without loss of viability. Quinn, Jane C; Molinek, Michael; Nowakowski, Tomasz J.; Mason, John O.; Price, David J. // BMC Neuroscience;2010, Vol. 11, p26 

    Background: Embryonic stem (ES) cells can differentiate into all cell types and have been used extensively to study factors affecting neuronal differentiation. ES cells containing mutations in known genes have the potential to provide useful in vitro models for the study of gene function during...

  • Dynamic expression patterns of imprinted genes in human embryonic stem cells following prolonged passaging and differentiation. Mai, Xiuyun; Mai, Qingyun; Li, Tao; Zhou, Canquan // Journal of Assisted Reproduction & Genetics;Apr2011, Vol. 28 Issue 4, p315 

    Purpose: To evaluate the overall expression patterns of imprinted genes in human embryonic stem cells following long term culture and differentiation. Materials and methods: Expression levels of 65 imprinted genes determined by PCR array were analyzed in one human embryonic stem cell line...

  • Embryonic Stem Cells: Overcoming the Immunological Barriers to Cell Replacement Therapy. Lui, Kathy O.; Waldmann, Herman; Fairchild, Paul J. // Current Stem Cell Research & Therapy;Jan2009, Vol. 4 Issue 1, p70 

    The appeal of using embryonic stem (ES) cells for regenerative medicine lies in their pluripotency and resulting ability to differentiate into all somatic cell types. While graft rejection remains the greatest hurdle to their use in the clinic, several approaches have been proposed to protect...

  • New Human Embryonic Stem-Cell Lines to Be Made Available to Researchers.  // Ascribe Newswire: Medicine;3/3/2004, p20 

    Howard Hughes Medical Institute researchers at Harvard University announced today that they have derived 17 new human embryonic stem-cell lines. The new cell lines will be made available to researchers, although at this time United States policies prohibit the use of federal funds to investigate...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics